SOSean O'LEary

Sean O'LEary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sean O'LEary has a total of 261 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Outcomes Associated With Postoperative Dexamethasone Use After Adult Spinal Deformity Surgery

    by Anthony M. Price, Barbara Buccilli, Nathan Fredricks, Sean O’LEary, Soren Jonzzon, Christopher M. Bonfield, Scott L. Zuckerman, Daniel Jupiter

    Objective: Dexamethasone is commonly prescribed following adult spinal deformity (ASD) surgery; however, dexamethasone’s immunosuppressive effects on clinical outcomes in ASD surgery remain unclear. This study sought to: assess the effects of postoperative dexamethasone after ASD surgery, and evaluate the potential association between postoperative dexamethasone and complications.Methods: This TriNetX study identified adults who underwent ASD surgery from 2009–2024. Outcomes were explored at 30-day, 90-day, and 1-year time points among patients with any systemic dexamethasone exposure within 7 days of surgery. Primary outcomes included wound infection, sepsis, and perioperative hematoma. Secondary outcomes included respiratory failure, delirium, new-onset diabetes, and in-hospital mortality. Propensity score matching (PSM) and logistic regression assessed associations.Results: After PSM, 42,472 patients were included in both the dexamethasone and control cohorts. At 30 days, dexamethasone exposure was associated with higher odds of wound infection. At 90 days, these associations included elevated risks for wound infection, respiratory failure, delirium, and sepsis. By 1 year, dexamethasone use remained significantly associated with wound infection, delirium, and respiratory failure, however, hospital-recorded mortality was lower in the dexamethasone cohort.Conclusion: In this large cohort, postoperative dexamethasone exposure was associated with increased risks of infectious and hospital-based complications, including wound infection. These findings support the need for prospective studies to define safe perioperative protocols in complex spine surgery.


  • Open Access

    Exploring the association between pre- and post-operative patient attitudes, social support and patient-reported outcomes in elective spinal surgery

    by Abigail Jenkins, Faraaz Azam, Emmanuella Oduguwa, Michael Farid, Sean O'LEary, Jason Wang, Alejandra Possu, Jonathan Tao, Emmanuel Adeyemo, Paula Mofor, et al.

  • Prevalence of Guideline-Recommended Genetic Testing in Patients at Risk for Heritable Thoracic Aortic Disease

    by Ariadna Robledo, Sean O’LEary, Daniel Del Toro Pedrosa, Jorge Penalver, Rhea Sancassani

  • Optimal timing of PD-1 inhibitor immunotherapy administration to stereotactic radiosurgery in malignant gliomas: a propensity score–matched multi-institutional cohort study

    by Sean O’LEary, Allen Y. Fu, Vaughn A. Rogers, Blake Perdikis, Michael Farid, Kwadwo Darko, Srivats Srinivasan, Umaru Barrie, Hammad A. Khan, Matthew Z. Sun, et al.

    OBJECTIVE: The optimal order of treatment with programmed cell death protein 1 (PD-1) inhibitor immunotherapy and stereotactic radiosurgery (SRS) in malignant gliomas remains unclear. This study examined whether the timing of PD-1 inhibitor administration relative to SRS affects patient neurological outcomes and survival in a multi-institutional propensity score–matched cohort. METHODS: A retrospective analysis was conducted using the TriNetX Research Network database (2005–2022), identifying adults with malignant gliomas who received SRS and at least one PD-1 inhibitor. Patients were stratified into two cohorts based on whether PD-1 inhibition occurred 8 weeks before SRS (pre-SRS) versus after SRS (post-SRS). Propensity score matching (1:1) was performed for demographics, comorbidities, and relevant medications. Clinical outcomes, including mortality, cognitive impairments, cranial nerve deficits, seizures, hemorrhagic complications, and functional impairments, were assessed over a 3-year follow-up period. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, and Kaplan-Meier (KM) survival analyses were used to compare cumulative incidence rates. RESULTS: Before matching, the pre-SRS (n = 429) versus post-SRS (n = 381) cohorts differed significantly in sex (female, unknown), ethnicity (Hispanic/Latino, unknown), race (Asian, American Indian, other), overweight/obesity, type 2 diabetes mellitus, lipidemia, anticoagulant use, durvalumab use, and atezolizumab use (all p < 0.05). After propensity score matching (n = 233 per group), PD-1 inhibition pre- versus post-SRS showed no significant differences in baseline characteristics except for age (mean 63.50 [SD 11.84] years vs 63.36 [SD 10.82] years, p = 0.012) and tremelimumab use (n = 0 [0%] vs n = ≤ 10 [≤ 4.29%], p = 0.001). In propensity score–matched patients, PD-1 inhibitor use before SRS was associated with significantly higher odds of cognitive impairments (OR 1.75, 95% CI 1.04–2.98, p = 0.034), cranial nerve deficits (OR 2.00, 95% CI 1.11–3.69, p = 0.021), and mortality (OR 1.53, 95% CI 1.06–2.20, p = 0.023), while other outcomes including behavioral/mood changes (OR 0.91, p = 0.726), gait/coordination disorders (OR 1.28, p = 0.421), hemorrhagic complications (OR 0.97, p = 0.930), motor deficits (OR 0.86, p = 0.590), seizures/epilepsy (OR 0.99, p = 0.971), and sensory disturbances (OR 0.91, p = 0.737) showed no significant differences. KM analyses confirmed elevated risks of cognitive impairment (p = 0.0076), cranial nerve deficits (p = 0.0104), and mortality (p = 0.0109) in the pre-SRS group. CONCLUSIONS: Pre-SRS PD-1 inhibitor use was associated with more neurological deficits and lower survival, highlighting the need for prospective studies on optimal SRS immunotherapy timing in malignant gliomas.


  • Impacts of Prior Lumbar Laminectomy and Fusion on Long Segment Thoracolumbar Fusion for Adult Spinal Deformity

    by Sruja Arya, Joonoh Lee, Gillian Witten, Sean O’LEary, Dhillon Advano, Khashayar Mozaffari, Keith George, Kristen Hall, Omar Akbik, Carlos A. Bagley, et al.

    Study Design.: Retrospective Cohort Study Objective.: This study examined whether prior lumbar laminectomy or fusion at overlapping levels affects outcomes after long-segment thoracolumbar fusion for ASD. Summary of Background Data.: Adult spinal deformity (ASD) from age-related degeneration is increasing with an aging population. Long-segment thoracolumbar fusion is an option for adults with severe deformity or misalignment, but prior lumbar surgery may increase operative complexity and prolong recovery. Methods.: We reviewed 219 adults undergoing ≥4-level thoracolumbar fusion for ASD (2016–2021), grouped by prior overlapping fusion (n=65), laminectomy alone (n=36), or no lumbar surgery (n=118). The primary outcome was time to revision, evaluated using Kaplan-Meier and adjusted Cox analyses. Secondary outcomes were complications and change in Oswestry Disability Index (ODI) among patients with paired scores and ≥6 months of follow-up. Results.: Patients with prior lumbar fusion more frequently presented with sagittal deformity or mechanical failure, lower median Cobb angle, and greater sagittal vertical axis than surgery-naïve patients. Revision-free survival differed significantly among groups (log-rank χ²=20.0, P P P =0.186). Among 174 patients with paired ODI scores, median ODI improvement was 14 points in surgery-naïve patients, 6 points after prior laminectomy, and 10 points after prior fusion ( P =0.478). Minimum clinically important difference achievement did not differ among groups (52.2%, 40.7%, and 42.1%, respectively; P =0.376), nor did postoperative complication rates. Conclusion.: Prior overlapping lumbar fusion, but not prior laminectomy, was independently associated with greater revision risk after long-segment thoracolumbar fusion for ASD. Prior fusion and laminectomy should be considered separately during preoperative counseling and operative planning.

  • Open Access

    Renal cell carcinoma intraspinal metastases: a peripheral nerve sheath tumor mimic. Illustrative case

    by Sean O’LEary, Aiyana Adams, Christian Ogasawara, Marc Prablek, Rishi Lall

    BACKGROUND: Renal cell carcinoma (RCC) metastases to the spinal cord, cauda equina, nerve root, and dorsal root ganglion (DRG) are rare and can mimic benign peripheral nerve sheath tumors. OBSERVATIONS: A PRISMA-guided review of the PubMed/MEDLINE, Scopus, Embase, and Google Scholar databases identified 47 studies consisting of 57 patients with intradural extramedullary (IDEM), intramedullary spinal cord, or nerve root/DRG RCC metastases. The mean age was 59.4 ± 12.4 years, 71.9% were male, and clear cell RCC was the most common subtype (59.6%). Lesions involved intramedullary spinal cord metastasis in 57.9%, IDEM disease in 31.6%, and primary nerve root/DRG metastases in 10.5%. IDEM and nerve root lesions most often caused pain and radiculopathy, whereas intramedullary lesions uniformly produced myelopathy or motor weakness and more frequent sphincter dysfunction. Surgery was performed in 71.9% of patients, with gross-total resection in 80.5% of operative cases. The illustrative case was a symptomatic left C6–7 foraminal mass with focal Ga-68 DOTATATE uptake and progressive radiculopathy with mild left upper extremity weakness that mimicked schwannoma but was confirmed intraoperatively as metastatic RCC; resection and stabilization achieved durable symptom resolution. LESSONS: New foraminal or dumbbell-shaped lesions in patients with malignancy warrant tissue diagnosis to guide appropriate metastasis-directed management. https://thejns.org/doi/10.3171/CASE26244


  • Open Access

    Intracranial hemorrhage in acquired hemophilia A: illustrative case

    by Gillian Witten, Sean O’LEary, Khashayar Mozaffari, Cody Wolfe, Toral R. Patel, Alex Valadka

    BACKGROUND: Acquired hemophilia A (AHA) is a rare autoimmune coagulopathy caused by factor VIII inhibitors. Intracranial hemorrhage is an uncommon but potentially devastating presentation. The authors systematically reviewed reported cases of AHA-associated intracranial hemorrhage and present an illustrative case highlighting diagnostic and management considerations. OBSERVATIONS: A PRISMA-guided review of PubMed, ScienceDirect, and Scopus included original case reports describing clinical features, management, or outcomes. Sixteen patients were identified, with a median age of 66.5 (IQR 15.5) years and slight male predominance (56%). Hemorrhage types included intracerebral hemorrhage (50%), acute subdural hematoma (38%), subarachnoid hemorrhage (12%), and intraventricular hemorrhage (19%); 3 patients had multiple hemorrhage types. Prolonged activated partial thromboplastin time was reported in 14 patients (mean 76.0 ± 28.6 seconds) with markedly reduced factor VIII activity. Hemostatic therapy was administered in 81% of patients and immunosuppression in 69%. Among those receiving hemostatic therapy, bypassing agents were used in 56% (recombinant activated factor VIIa 50%; activated prothrombin complex concentrate 19%). Surgical intervention occurred in 31%. The overall survival was 62%, and 30% of survivors achieved full neurological recovery. An additional case describes an 80-year-old woman with acute subdural hematoma who underwent decompressive craniectomy before AHA diagnosis and recovered after factor-directed and immunosuppressive therapies. LESSONS: Intracranial hemorrhage in AHA is rare but highly morbid. Early recognition of isolated prolonged activated partial thromboplastin time and prompt initiation of bypassing agents may improve outcomes. https://thejns.org/doi/10.3171/CASE26195

  • Open Access

    Frailty, Bone Health, and Radiographic Predictors of Complications After Long-Segment Fusion for Adult Spinal Deformity

    by Sean O'LEary, Milan Sivakumar, Gillian Witten, Sam Bazzi, Dhillon Advano, Sruthi Ranganathan, Mina Guirguis, Srivats Srinivasan, Omar Akbik, Salah Aoun, et al.

  • Real-Time Pressure Sensing Is Associated With Reduced Complication Rates in Percutaneous Spinal Cord Lead Implantation: A Retrospective Cohort Analysis

    by Sean O'LEary, Anthony M. Price, Christopher File, Teerth Y. Patel, Nathan Fredricks, Kishan Akash Patel, Anne-Cecile Lesage, Liliana Camarillo-Rodriguez, Christian Ogasawara, Matias Costa, et al.

    BACKGROUND AND OBJECTIVES: CompuFlo provides real-time pressure feedback to identify the epidural space during spinal cord stimulator (SCS) implantation. METHODS: We compared CompuFlo with standard loss of resistance. Single-center retrospective cohort of consecutive SCS implantations by one surgeon using CompuFlo or loss of resistance. Primary outcome: composite of any cerebrospinal fluid leak, epidural blood patch, or postoperative radiculopathy. Secondary outcomes: each component, needle-pass burden (mean passes per electrode; ≥2 passes), operative time, and hospital length of stay (LOS). Models adjusted for age, sex, and entry level. RESULTS: Seventy-nine patients were included (CompuFlo n = 40; standard n = 39). CompuFlo patients were older, with similar sex and race distributions. Entry level differed numerically between groups. Multiple attempts, mean needle passes per electrode, and LOS were similar. In adjusted analyses, CompuFlo guidance was associated with lower odds of any complication (adjusted odds ratio 0.09, 95% CI 0.00-0.90; P = .039). Individual complications, ≥2 passes, pass rate, operative time, and LOS did not differ. Among CompuFlo cases with pressure recordings (n = 19), first-pass high pre-epidural pressures averaged 137.6 ± 8.4 mm Hg and low epidural pressures averaged 20.0 ± 13.6 mm Hg. CONCLUSION: CompuFlo-guided epidural access during SCS implantation was associated with lower adjusted odds of perioperative complications without increased needle-pass burden or LOS. Larger prospective studies are warranted.

  • Assessing the Assessors: Comparative performance of frailty and nutritional metrics in predicting 30-Day morbidity and mortality after cranial neurosurgery

    by Michael Farid, Justin Wang, Blake Perdikis, Nicolai Blasdel, Kwadwo Darko, Sean O’LEary, Umaru Barrie, Hammad Khan, Salah G. Aoun